A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : BMMs / bone marrow-derived macrophages

[Related PubMed/MEDLINE]
Total Number of Papers: 313
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   BMMs  (>> Co-occurring Abbreviation)
Long Form:   bone marrow-derived macrophages
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Artemisinin inhibits breast cancer-induced osteolysis by inhibiting osteoclast formation and breast cancer cell proliferation. ART
2019 Atg5 Supports Rickettsia australis Infection in Macrophages In Vitro and In Vivo. IL-1beta, LC3
2019 Autophagy exerts pivotal roles in regulatory effects of 1alpha,25-(OH)2D3 on the osteoclastogenesis. OCPs
2019 Berberine Suppresses RANKL-Induced Osteoclast Differentiation by Inhibiting c-Fos and NFATc1 Expression. BBR, LPS, NFATc1, OSCAR, RANKL
2019 Bone marrow-derived macrophage contributes to fibrosing steatohepatitis through activating hepatic stellate cells. BMT, C3ar1, ER, HFHC, HSCs, MCD, NASH
2019 Cholera toxin B induces interleukine-1beta production from resident peritoneal macrophages through pyrin as well as NLRP3 inflammasome. CTB, IL-1beta, PKA
2019 Cooperation of PU.1 With IRF8 and NFATc1 Defines Chromatin Landscapes During RANKL-Induced Osteoclastogenesis. IRF, NFATc1, OC, RANKL
2019 Cyclic Dinucleotides Inhibit Osteoclast Differentiation Through STING-Mediated Interferon-beta Signaling. CDNs, IFN, IFNAR, M-CSF, RANKL
2019 Cyclin-dependent kinase 8/19 inhibition suppresses osteoclastogenesis by downregulating RANK and promotes osteoblast mineralization and cancellous bone healing. CDK8, DC-STAMP, NF-kappaB, NFATc1, TRAP
10  2019 Effects of adiponectin on osteoclastogenesis from mouse bone marrow-derived monocytes. M-CSF, RANKL, TRAP
11  2019 EPC-derived exosomes promote osteoclastogenesis through LncRNA-MALAT1. EPCs
12  2019 Estrogen-related receptor gamma negatively regulates osteoclastogenesis and protects against inflammatory bone loss. ERRgamma, NF-kappaB, RANKL
13  2019 Generation of Bone Marrow-Derived Macrophages for InVitro Infection Experiments. CSF-1
14  2019 Interleukin 29 inhibits RANKL-induced osteoclastogenesis via activation of JNK and STAT, and inhibition of NF-kappaB and NFATc1. CTSK, IL, IL-28Ralpha, MMP-9, NF-kappaB, NFATc1, PBMCs, RANKL, TRAP
15  2019 Lipoteichoic acid of Enterococcus faecalis inhibits osteoclastogenesis via transcription factor RBP-J. LTA
16  2019 MicroRNA-1225 activates Keap1-Nrf2-HO-1 signalling to inhibit TNFalpha-induced osteoclastogenesis by mediating ROS generation. miR-1225, RANKL, ROS, TNF, TRAP
17  2019 miR-142-5p promotes the osteoclast differentiation of bone marrow-derived macrophages via PTEN/PI3K/AKT/FoxO1 pathway. miRNAs
18  2019 Nrf2 deficiency aggravates the increase in osteoclastogenesis and bone loss induced by inorganic arsenic. Nrf2, ROS
19  2019 PIP5k1beta controls bone homeostasis through modulating both osteoclast and osteoblast differentiation. ---
20  2019 Reversal of Osteoporotic Activity by Endothelial Cell-Secreted Bone Targeting and Biocompatible Exosomes. EC
21  2019 Sirtuin 1 inhibits TNF-alpha-mediated osteoclastogenesis of bone marrow-derived macrophages through both ROS generation and TRPV1 activation. ROS, SIRT1, TNF, TRPV1
22  2019 Streptococcus gordonii induces bone resorption by increasing osteoclast differentiation and reducing osteoblast differentiation. ---
23  2019 Targeting vascular endothelial growth factor ameliorates PMMA-particles induced inflammatory osteolysis in murine calvaria. PMMA, TNF, VEGF, vWF
24  2019 Taxifolin Inhibits Receptor Activator of NF-kappaB Ligand-Induced Osteoclastogenesis of Human Bone Marrow-Derived Macrophages in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo. RANKL
25  2019 The effects of trehalose glycolipid presentation on cytokine production by GM-CSF macrophages. TGLs
26  2019 The use of apocynin inhibits osteoclastogenesis. APO, NAC, NOX, ROS, TRAP
27  2018 A flavonoids compound inhibits osteoclast differentiation by attenuating RANKL induced NFATc-1/c-Fos induction. MAPKs, NFATc-1, RANKL, STAT3, TFs
28  2018 A prenylated flavonoid, 10-oxomornigrol F, exhibits anti-inflammatory effects by activating the Nrf2/heme oxygenase-1 pathway in macrophage cells. COX-2, HO, IL, iNOS, LPS, MAPK, NAC, NO, NQO1, Nrf2, OMF, ROS, TNF-alpha
29  2018 Activation of NLRP3 inflammasome in macrophages by mycoplasmal lipoproteins and lipopeptides. IL-1beta, NLRP3, TLR2
30  2018 Anti-Osteoporotic Effects of Polysaccharides Isolated from Persimmon Leaves via Osteoclastogenesis Inhibition. MAPKs, NFATc1, RANKL
31  2018 Artesunate inhibits RANKL-induced osteoclastogenesis and bone resorption in vitro and prevents LPS-induced bone loss in vivo. ART, LPS
32  2018 Aryl hydrocarbon receptor activation by benzo(a)pyrene inhibits proliferation of myeloid precursor cells and alters the differentiation state as well as the functional phenotype of murine bone marrow-derived macrophages. AhR, BaP, BMCs, CXCL1, HK, IL, MHC-II, NO, TNF
33  2018 Benzo(a)pyrene attenuates the pattern-recognition-receptor induced proinflammatory phenotype of murine macrophages by inducing IL-10 expression in an aryl hydrocarbon receptor-dependent manner. AhR, BaP, IL, MHC-II, NO, PAMPs, PRRs, TNF
34  2018 Berberine inhibits IL-21/IL-21R mediated inflammatory proliferation of fibroblast-like synoviocytes through the attenuation of PI3K/Akt signaling pathway and ameliorates IL-21 mediated osteoclastogenesis. AA-FLS, BBR, IL-1beta, IL-23, IL-6, MMP9, mTOR, NF-kappaB, NFATc1, PTEN, TNF-alpha, TRAP
35  2018 Crocin inhibits RANKL‑induced osteoclastogenesis by regulating JNK and NF‑kappaB signaling pathways. RANKL
36  2018 Cryptotanshinone inhibits RANKL-induced osteoclastogenesis by regulating ERK and NF-kappaB signaling pathways. CTS, NFAT, OS, RANKL, TRAP
37  2018 Cysteinyl leukotriene receptor 1 (cysLT1R) regulates osteoclast differentiation and bone resorption. cysLT1R
38  2018 Daphnetin inhibits RANKL-induced osteoclastogenesis in vitro. RANKL, ROS
39  2018 Data on the expression of CXCR3 ligands and pro-inflammatory cytokines in macrophages and CD4+ T cells after stimuli of CXCR3 ligands. CXCR3
40  2018 Effect of remifentanil on pre-osteoclast cell differentiation in vitro. pre-OCs
41  2018 Effects of Melatonin and Its Underlying Mechanism on Ethanol-Stimulated Senescence and Osteoclastic Differentiation in Human Periodontal Ligament Cells and Cementoblasts. AMPK, EtOH, hPDLCs, IL, MAPK, mTOR, NFAT, PIN1, ROS, SASP
42  2018 Endogenous PGI2 signaling through IP inhibits neutrophilic lung inflammation in LPS-induced acute lung injury mice model. BMDCs, PGI2, WT
43  2018 Endothelial Progenitor Cells Enhance the Migration and Osteoclastic Differentiation of Bone Marrow-Derived Macrophages in vitro and in a Mouse Femur Fracture Model through Talin-1. EPCs
44  2018 Galectin-3 Enhances Avian H5N1 Influenza A Virus-Induced Pulmonary Inflammation by Promoting NLRP3 Inflammasome Activation. Gal-3KO, NLRP3, WT
45  2018 Increased level of cell-derived microparticles in the cyst fluids of odontogenic keratocysts. DCs, MPs, NFATc1, OKCs, RCs, TRAP
46  2018 Inhibition of murine herpesvirus-68 replication by IFN-gamma in macrophages is counteracted by the induction of SOCS1 expression. RTA, SOCS1, TLR3
47  2018 Inhibitor of Bruton's tyrosine kinases, PCI-32765, decreases pro-inflammatory mediators' production in high glucose-induced macrophages. BTK, DN, HG, IL-1beta, MCP-1, TNF-alpha
48  2018 Iron-induced oxidative stress stimulates osteoclast differentiation via NF-kappaB signaling pathway in mouse model. ROS
49  2018 Legionella pneumophila Is Directly Sensitive to 2-Deoxyglucose-Phosphate via Its UhpC Transporter but Is Indifferent to Shifts in Host Cell Glycolytic Metabolism. 2DG, TLR
50  2018 LncRNA KCNQ1OT1 ameliorates particle-induced osteolysis through inducing macrophage polarization by inhibiting miR-21a-5p. IL, iNOS, PMMA, RIP, TNF-alpha
51  2018 Loss of ATF3 exacerbates liver damage through the activation of mTOR/p70S6K/ HIF-1alpha signaling pathway in liver inflammatory injury. ATF3, HIF, HMGB1, IRI, KO, mTOR, PHD1
52  2018 Murine Hepatitis Virus nsp14 Exoribonuclease Activity Is Required for Resistance to Innate Immunity. CoVs, dsRNA, ExoN, IFN-beta, MHV, nsp14
53  2018 Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor kappaB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-kappaB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages. CTR, CTSK, NFATc1, NGA, RANKL, TRAP
54  2018 NF-kappaB/let-7f-5p/IL-10 pathway involves in wear particle-induced osteolysis by inducing M1 macrophage polarization. ---
55  2018 Overexpressed miR-145 inhibits osteoclastogenesis in RANKL-induced bone marrow-derived macrophages and ovariectomized mice by regulation of Smad3. M-CSF, miRs, RANKL, TRAP
56  2018 Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastogenesis. RANKL, SH3BP2
57  2018 Polyphyllin I Ameliorates Collagen-Induced Arthritis by Suppressing the Inflammation Response in Macrophages Through the NF-kappaB Pathway. CIA, IFN, IL-1R, LPS, MYD88, PEMs, PPI, RA, TAK1, TRAF
58  2018 Propofol promotes osteoclastic bone resorption by increasing DC-STAMP expression. DC-STAMP, M-CSF, RANKL, TRAP
59  2018 Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites. PVs
60  2018 Rab44, a novel large Rab GTPase, negatively regulates osteoclast differentiation by modulating intracellular calcium levels followed by NFATc1 activation. NFATc1
61  2018 Remifentanil Negatively Regulates RANKL-Induced Osteoclast Differentiation and Bone Resorption by Inhibiting c-Fos/NFATc1 Expression. M-CSF, TRAP
62  2018 REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulation. RANKL
63  2018 Rutaecarpine attenuates osteoclastogenesis by impairing macrophage colony stimulating factor and receptor activator of nuclear factor kappa-B ligand-stimulated signalling pathways. M-CSF, NFATc1, RANKL
64  2018 Size-dependent superparamagnetic iron oxide nanoparticles dictate interleukin-1beta release from mouse bone marrow-derived macrophages. IL, SPIONs
65  2018 Suppression Effect of Astaxanthin on Osteoclast Formation In Vitro and Bone Loss In Vivo. AST, BMD, DC-STAMP, NFAT, TRAP
66  2018 Synergistic effect of co-stimulation of membrane and endosomal TLRs on chicken innate immune responses. MPLA, NO, TLR
67  2018 TGF-beta promotes fibrosis after severe acute kidney injury by enhancing renal macrophage infiltration. ---
68  2018 The class D scavenger receptor CD68 contributes to mouse chronic liver injury. MCDHF
69  2018 The respiratory syncytial virus fusion protein formulated with a polymer-based adjuvant induces multiple signaling pathways in macrophages. PRRs, RSV
70  2018 TNF‑alpha and RANKL promote osteoclastogenesis by upregulating RANK via the NF‑kappaB pathway. NF
71  2018 Toll-like receptor signaling in macrophages is regulated by extracellular substrate stiffness and Rho-associated coiled-coil kinase (ROCK1/2). PA, TLRs, TNF-alpha
72  2018 Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR. MAPKs, NF-kappaB
73  2018 [Effect of lipopolysaccharide on osteoclasts formation and bone resorption function and its mechanism]. CCK-8, LPS, M-CSF, TRAP
74  2018 [The effects of macrophages with high expression of TL1A on activation and proliferation of hepatic stellate cells in vitro]. alpha-SMA, CM, ELISA, LPS, PMs, WT
75  2017 3',4',7,8-Tetrahydroxyflavone inhibits RANKL-induced osteoclast formation and bone resorption. CTR, NFATc1, RANKL
76  2017 A FKBP5 mutation is associated with Paget's disease of bone and enhances osteoclastogenesis. PDB
77  2017 Aldose reductase (AKR1B) deficiency promotes phagocytosis in bone marrow derived mouse macrophages. AKR, AR, LPS, WT
78  2017 ATF3 modulates calcium signaling in osteoclast differentiation and activity by associating with c-Fos and NFATc1 proteins. ATF3, NFATc1, TRAP
79  2017 Blockade of Notch signaling promotes acetaminophen-induced liver injury. Hes1, HMGB1, NS, TLR4 KO, WT
80  2017 DJ-1/PARK7 Impairs Bacterial Clearance in Sepsis. ROS
81  2017 Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts. DHA, M-CSF, NFATc1, RANKL
82  2017 DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis. DAP12, DOK3, ITAM, M-CSF, OPG, RANKL, TLR, TREM2, WT
83  2017 Down-regulation of Irf8 by Lyz2-cre/loxP accelerates osteoclast differentiation in vitro. BMCs, IRF8
84  2017 F4/80 inhibits osteoclast differentiation via downregulation of nuclear factor of activated T cells, cytoplasmic 1. NFATc1, TM7
85  2017 Fexaramine Inhibits Receptor Activator of Nuclear Factor-kappaB Ligand-induced Osteoclast Formation via Nuclear Factor of Activated T Cells Signaling Pathways. FXR, M-CSF, NF
86  2017 Identification and Characterization of MicroRNA Differentially Expressed in Macrophages Exposed to Porphyromonas gingivalis Infection. IL-10, miRNAs, TNF-alpha
87  2017 Interaction of the CD43 Sialomucin with the Mycobacterium tuberculosis Cpn60.2 Chaperonin Leads to Tumor Necrosis Factor Alpha Production. JNK, PI3K, PLCgamma, TGF-beta, TNF-alpha
88  2017 Lithium chloride inhibits titanium particle-induced osteoclastogenesis by inhibiting the NF-kappaB pathway. LiCl, PBS, PIO
89  2017 Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling pathway. ALP, Col1alpha, JNK, MF, MMP9, NF-kappaB, NFATc1, OCN, OPN, TRAP
90  2017 Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR. MAPKs, NF-kappaB, PXR
91  2017 Melittin inhibits osteoclast formation through the downregulation of the RANKL-RANK signaling pathway and the inhibition of interleukin-1beta in murine macrophages. ERK, IL-1beta, M-CSF, MAPKs, MMP-9, MNCs, NF-kappaB, NFATc1, RANKL, TRAF6, TRAP
92  2017 miRNA-340 inhibits osteoclast differentiation via repression of MITF. M-CSF, MITF, NF, qRT-PCR, TRAP
93  2017 Modulation of Macrophage Responses by CMX, a Fusion Protein Composed of Ag85c, MPT51, and HspX from Mycobacterium tuberculosis. BCG, rBCG-CMX, TB
94  2017 mTORC1 Inhibits NF-kappaB/NFATc1 Signaling and Prevents Osteoclast Precursor Differentiation, In Vitro and In Mice. mTORC1, NF-kappaB, NFATc1
95  2017 Negative feedback loop of bone resorption by NFATc1-dependent induction of Cadm1. Cadm1, NFATc1, RANKL
96  2017 Nitro-oleic acid regulates growth factor-induced differentiation of bone marrow-derived macrophages. CSFs, ERK, GM-CSF, M-CSF
97  2017 Osteoblast Hypoxia-Inducible Factor-1alpha Pathway Activation Restrains Osteoclastogenesis via the Interleukin-33-MicroRNA-34a-Notch1 Pathway. HIF-1alpha, IL-33, miR-34a-5p, OPG
98  2017 Osteoblast-derived Laminin-332 is a novel negative regulator of osteoclastogenesis in bone microenvironments. EMR1, Lm-332, MAPKs, NF-kappaB
99  2017 Osteoclast differentiation gene expression profiling reveals chemokine CCL4 mediates RANKL-induced osteoclast migration and invasion via PI3K pathway. OCs
100  2017 Peucedanum japonicum Thunb. ethanol extract suppresses RANKL-mediated osteoclastogenesis. CREB, NFATc1, PEE, PLC, RANKL, TRAP